Meeting on redacting commercially confidential information (CCI) in clinical reports and anonymising clinical reports for the purpose of publication

• Date:
  Montag, 6 Juli 2015, Ganztägig
• Ort:
  European Medicines Agency, Amsterdam, the Netherlands

The European Medicines Agency (EMA) is organising a face-to-face meeting on 6 July 2015 at the EMA to allow more detailed discussions on guidance being developed on anonymisation of clinical reports for publication and on redacting commercially confidential information in clinical reports. This meeting follows the webinar held on 24 June which provided an update on the implementation of the policy on the publication of clinical data. Stakeholder organisations have been contacted to nominate experts as participants in this meeting. Places limited. Registration by invitation only. Registration closed.

Documents

Agenda - Meeting on redacting commercially confidential information (CCI) in clinical reports and anonymising clinical reports for the purpose of publication

Draft Reference Number: EMA/431518/2015

Summary - Meeting on redacting commercially confidential information (CCI) in clinical reports and anonymising clinical reports for the purpose of publication

Reference Number: EMA/457830/2015

Presentation - Guidance to pharmaceutical industry on redacting commercially confidential information (CCI) in clinical reports and process: Meeting on redacting commercially confidential information (CCI) in clinical re...

Presentation - Guidance on the anonymisation of clinical reports for the purpose of publication - Meeting on redacting commercially confidential information (CCI) in clinical reports and anonymising clinical reports for ...